EXAS Stock Soars on Abbott Takeover Talks: Exact Sciences Jumps Over 20% on November 19, 2025
Exact Sciences shares surged as much as 28% on November 19 after reports that Abbott Laboratories is in advanced talks to acquire the company. EXAS hit a new 52-week high of $89.67 before settling near $81.79, up 17% by mid-afternoon. Trading volume exceeded 10.4 million shares, with about $645 million in stock changing hands. Negotiations could still face delays or collapse, according to sources.